The American Journal of Managed Care

Economic Burden of Hypoglycemia With Basal Insulin in Type 2 Diabetes

We speculate that earlier basal insulin initiation (ie, when disease burden is low) may incur a lower hypoglycemia risk, whereas delayed insulin (ie, when disease burden is high) may require closer ...
The Lancet

Dual incretin therapy for type 2 diabetes inadequately controlled on basal insulin in Chinese adults: clinical and research implications

Băi wén bù rú yī jiàn“Seeing for oneself is a hundred times better than hearing from others.”Chinese Proverb from the Book of ...
Medscape

Once-Weekly Combo Diabetes Jab Wins EMA Recommendation

Reducing injection burden has long been a priority in diabetes care. Now, a weekly, fixed-dose combination of basal insulin and a GLP-1 receptor agonist is one step closer to approval in Europe.
MobiHealthNews

Dexcom launches new titration module for basal insulin initiation

At the 61st annual European Association for the Study of Diabetes Conference (EASD) this week in Vienna, Austria, glucose monitoring company Dexcom introduced its new offering, the Dexcom Smart Basal, ...
Morningstar

Novo Nordisk resubmits Awiqli® to the FDA with potential to be the first once-weekly basal insulin treatment for adults with type 2 diabetes

BAGSVÆRD, Denmark and PLAINSBORO, N.J., Sept. 29, 2025 /PRNewswire/ -- Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration ...